mrna - Search News

Moderna, Q4 and MRNA

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

Despite a significant revenue decline, Moderna Inc (MRNA) focuses on strategic program prioritization and cost management to drive future growth.

Hosted on MSN · 1d

Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly

Biotechnology company Moderna (NASDAQ:MRNA) in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue guidance of $2 billion at the midpoint came in 9.

The Motley Fool on MSN · 20h

Moderna (MRNA) Q4 2024 Earnings Call Transcript

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised,

Houston Chronicle · 1d

Moderna: Q4 Earnings Snapshot

Moderna Inc. (MRNA) on

Investing.com on MSN · 23h

Earnings call transcript: Moderna Q4 2024 sees revenue drop, market reacts

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and the market responded with a notable drop in premarket trading.

Moderna (MRNA) Is About to Report Tomorrow. Here Is What to Expect

Pharma giant Moderna (MRNA) is set to release its Q4 2024 results on February 14. MRNA stock has lost about 64% over the past ...

Bill to ban mRNA vaccines passes out of House committee

A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...

23hon MSN

Feet first: Understanding how mRNA helps cells 'walk'

Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...

Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 295.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 786 shares of the ...

Mirage News4d

Mapping MRNA Through Its Life Cycle Within Cell

When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...

GEN - Genetic Engineering and Biotechnology News2d

Accelerating mRNA Vaccine Production

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...